Skip to content
Monday, February 6, 2023
Latest:
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
  • MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News

Biotech Stock Market News

Know First, Act First

  • Cannabis & Cancer
  • General
  • Coronavirus
  • Financing & Fiscal
  • Shareholders

Coronavirus

BIOTCHNO Coronavirus 

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

January 31, 2021April 30, 2021 vanessa

Canada NewsWire SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS S. KOREAN FIRM COMMITTED

Read more
BIOTCHNO Coronavirus 

SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study

January 25, 2021April 30, 2021 vanessa

Canada NewsWire Company Intends to Use Patient Data for Emergency Use Authorization (EUA)Submission to U.S. FDA TORONTO, Jan. 25, 2021 /PRNewswire/ – SQI

Read more
BIOTCHNO Coronavirus 

Providence Therapeutics COVID-19 Vaccine Receives Health Canada Authorization to Begin Clinical Trials

December 23, 2020April 30, 2021 vanessa

Canada NewsWire mRNA vaccine is first fully made-in-Canadavaccine to undergo trials TORONTOand CALGARY, AB, Dec. 23, 2020 /CNW/ – Providence Therapeutics today announced

Read more
BIOTCHNO Coronavirus 

Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week

December 15, 2020April 30, 2021 vanessa

Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week BANGALORE, INDIA, Dec

Read more
BIOTCHNO Coronavirus 

Ichor Blood Services Expands Covid-19 Travel Testing Program to Include Travel to Hawaii

November 23, 2020April 30, 2021 vanessa

Canada NewsWire CALGARY, AB, Nov. 23, 2020 CALGARY, AB,Nov. 23, 2020/CNW/ – Ichor Blood Services, a private Covid-19 test facilitator

Read more
BIOTCHNO Coronavirus 

RimotHEALTH provides screening platform to Acadian Seaplants for a safer workplace during COVID-19 pandemic and beyond

November 18, 2020April 8, 2021 vanessa

Canada NewsWire DARTMOUTH, NS, Nov. 18, 2020 Developed inCanada, RimotHEALTH is a turnkey workplace safety screening solution to further protect

Read more
BIOTCHNO Coronavirus 

The Top 3 Companies Racing to Create COVID-19 Vaccine

May 5, 2020May 24, 2021 Desiree Justice BioNTech, BNTX, coronavirus, COVID-19, GILD, Gilead Sciences, National Institute of Allergy and Infectious Diseases, PFE, vaccine

The coronavirus is still wreaking havoc around the world. To date, total confirmed global cases are up to 3.6 million,

Read more

Cannabis

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
BIOTCHNO Cannabis & Cancer 

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

The Valens Company Expands Cannabis 2.0 & 3.0
BIOTCHNO Cannabis & Cancer 

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar
ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057